epirubicin has been researched along with Cardiovascular Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, X; Jing, T; Sun, Y; Wang, F; Xu, C; Zhang, C | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S | 1 |
| Di Mauro, M; Ficorella, C; Fratini, S; Mancini, M; Penco, M; Procaccini, V; Ricevuto, E; Romano, S; Stifano, G | 1 |
| Bighin, C; Del Mastro, L; Lunardi, G; Schettini, G; Stevani, I; Vannozzi, MO; Venturini, M | 1 |
| Seiter, K | 1 |
| Bria, E; Calabretta, F; Carpino, A; Cognetti, F; Cuppone, F; Ferretti, G; Nisticò, C; Sperduti, I; Terzoli, E; Toglia, G; Tomao, S; Vitelli, G | 1 |
| Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M | 1 |
| Brynjolf, I; Dombernowsky, P; Fogh, J; Hansen, M; Havsteen, H; Jensen, JB; Munck, O; Nielsen, D | 1 |
| Maciejewicz, J; Pawlicki, M; Zuchowska-Vogelgesang, B | 1 |
2 review(s) available for epirubicin and Cardiovascular Diseases
| Article | Year |
|---|---|
Chemotherapy plus estramustine for management of castration-resistant prostate cancer: meta-analysis of randomized controlled trials.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Combined Modality Therapy; Docetaxel; Epirubicin; Epothilones; Estramustine; Fatigue; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Orchiectomy; Paclitaxel; Peripheral Nervous System Diseases; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine | 2014 |
Toxicity of the topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases | 2005 |
4 trial(s) available for epirubicin and Cardiovascular Diseases
| Article | Year |
|---|---|
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Staging; Probability; Prospective Studies; Receptor, ErbB-2; Risk Assessment; Soft Tissue Neoplasms; Statistics, Nonparametric; Survival Rate; Trastuzumab; Treatment Outcome | 2003 |
Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin-paclitaxel in metastatic breast cancer patients.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiovascular Diseases; Echocardiography; Epirubicin; Female; Genes, erbB-2; Humans; Middle Aged; Monitoring, Physiologic; Myoglobin; Paclitaxel; Stroke Volume; Troponin T | 2007 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Remission Induction; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
[Clinical trial of epirubicin in patients with cardiologic contraindications for the use of doxorubicin].
Topics: Adult; Aged; Cardiovascular Diseases; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasms | 1987 |
4 other study(ies) available for epirubicin and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult | 2009 |
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult | 2010 |
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cardiovascular Diseases; Cyclophosphamide; Docetaxel; Doxorubicin; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Taxoids; Troponin I; Ventricular Function, Left | 2011 |
Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cardiovascular Diseases; Epirubicin; Female; Humans; Middle Aged; Stroke Volume | 1990 |